The Supreme Court appeared skeptical last week of arguments made by anti-abortion doctors seeking to roll back the availability of mifepristone, a drug that now constitutes nearly two-thirds of all abortions performed in the country.
This case marks the most significant abortion-related challenge before the justices since the Dobbs decision in June 2022, which overturned Roe v. Wade, thus eliminating the national right to abortion and disproportionately affecting Latinas in the U.S.
